Uncover key drivers, emerging technologies, and competitive movements shaping the plant-based vaccines market from 2025–2034 with trusted insights from The Business Research Company
What Is The Projected Valuation Of The Plant-Based Vaccines Market In The Period 2029-2034?
The plant-based vaccines market has experienced significant expansion in recent years. This market is set to increase from $1.66 billion in 2024 to $1.81 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 8.9%. Historically, this growth has been driven by obstacles in traditional vaccine production, the necessity for cost-effective vaccine manufacturing, the rise of plant molecular farming, diminished allergenic potential, and advancements in synthetic biology applications.
The plant-based vaccines market is expected to experience substantial growth over the next few years, with projections indicating it will reach $2.72 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 10.8%. This anticipated expansion during the forecast period is primarily driven by factors such as pandemic preparedness efforts, initiatives in global health security, the broadening scope of vaccine applications, and increasing adoption within the pharmaceutical industry. Noteworthy trends for the forecast period include continuous technological advancements in plant biotechnology, a growing emphasis on environmental sustainability, and the strategic integration of artificial intelligence and machine learning.
Access A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12144&type=smp
What Strategic Drivers Are Accelerating The Plant-Based Vaccines Market Expansion?
The increasing prevalence of infectious diseases is projected to drive expansion in the plant-based vaccine market. These diseases are illnesses caused by microorganisms like bacteria, viruses, fungi, or parasites. Plant-based vaccines, utilized in both traditional and contemporary medicine for numerous conditions, including infectious diseases, offer the potential for producing safe, potent, stable, and cost-effective prophylactics, vaccines, and therapeutic drugs. For example, the Global Tuberculosis Report, released in October 2022 by the Switzerland-based global health agency, the World Health Organization, reported an estimated 10.6 million global tuberculosis (TB) cases, equating to a rate of 134 cases per 100,000 people. The Southeast Asia region accounted for 45% of these TB cases, with Africa reporting the next highest share at 23%. Consequently, the widespread occurrence of infectious diseases is fueling the expansion of the plant-based vaccine market.
What Is The Detailed Segment Distribution Of The Plant-Based Vaccines Market?
The plant-based vaccines market covered in this report is segmented –
1) By Vaccine Type: Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types
2) By Source: Tobacco Plant, Maize, Potato, Other Sources
3) By Application: Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications
Subsegments:
1) By Bacterial Vaccines: Recombinant Bacterial Vaccines, Conjugate Bacterial Vaccines, DNA-Based Bacterial Vaccines
2) By Viral Vaccines: Inactivated Viral Vaccines, Live Attenuated Viral Vaccines, Subunit Viral Vaccines
3) By Parasite Vaccines: Recombinant Parasite Vaccines, DNA-Based Parasite Vaccines
4) By Other Vaccine Types: Fungal Vaccines, Multivalent Vaccines, Toxin-Based Vaccines
How Are Global Trends Impacting The Development Of The Plant-Based Vaccines Market?
A prominent trend gaining traction in the plant-based vaccine market is product innovation. Leading companies operating within the plant-based vaccine market are concentrating on developing novel products to maintain their standing. For instance, in February 2022, Medicago Inc., a Canada-based biopharmaceutical company, and GSK PLC, a UK-based pharmaceutical and biotechnology company, announced Health Canada’s approval of COVIFENZ, the COVID-19 vaccine. COVIFENZ, the COVID-19 vaccine, is the initial plant-based virus-like particles [VLP], recombinant, adjuvanted vaccine made available for COVID-19 disease. COVIFENZ utilizes the COVID-19-like particle (CoVLP) technology. This vaccine consists of recombinant spike (S) glycoproteins produced as virus-like particles (VLPs).
Who Are The Major Stakeholders Operating In The Plant-Based Vaccines Market?
Major companies operating in the plant-based vaccines market include Sanofi Pasteur SA, GlaxoSmithKline plc., British American Tobacco PLC, ICON Plc., Agenus Inc., Medicago Inc., Panacea Biotec Limited, Creative Biolabs Inc., InVitria, Fraunhofer USA Inc., Biodextris Inc., Intravacc B.V, Avesthagen Limited, Calyxt Inc., Zyus Life Sciences Inc., Mapp Biopharmaceutical Inc., Kentucky BioProcessing Inc., Planet Biotechnology Inc., Icon Genetics GmbH, PlantForm Corporation, LenioBio GmbH, iBio Inc., Lumen Bioscience Inc., Baiya Phytopharm Co. Ltd., Greenovation Biotech GmbH, Pevion Biotech AG
Download The Full Report Here:
https://www.thebusinessresearchcompany.com/report/plant-based-vaccines-global-market-report
Which Region Is Projected To Achieve The Fastest Growth In The Plant-Based Vaccines Market?
North America was the largest region in the plant-based vaccines market in 2024. The regions covered in the plant-based vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get A Report Customized For You Here:
https://www.thebusinessresearchcompany.com/customise?id=12144&type=smp
Browse Through More Reports Similar to the Global Plant-Based Vaccines Market 2025, By The Business Research Company
Motor Vehicle And Parts Dealers Global Market Report 2025
Automobiles And Heavy Equipment Global Market Report 2025
Electric Motor And Generator Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/electric-motor-and-generator-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
